Jokath

Timolol and Travoprost, the active ingredients in Jokath, are a beta‑blocker and prostaglandin analog combination presented as eye drops for ocular use. They treat primary open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Jokath as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jokath, a combination beta‑blocker and prostaglandin analog, is indicated for conditions that require reduction of intraocular pressure.

- Primary open‑angle glaucoma: lowers intraocular pressure to help prevent optic nerve damage. - Ocular hypertension: reduces intraocular pressure to lower the risk of progression to glaucoma. - Post‑surgical ocular pressure control: maintains target pressure after glaucoma surgery.

Jokath may cause ocular and systemic adverse reactions. Patients should be advised to report any new symptoms.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision. - Redness of the eye. - Dry eye or foreign‑body sensation. - Itching of the eyelids. - Temporary visual disturbances.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., swelling, rash, difficulty breathing). - Worsening of glaucoma or sudden loss of vision. - Macular edema. - Chest pain or bradycardia due to systemic beta‑blockade. - Bronchospasm in patients with asthma. - Persistent eye pain or inflammation.

Before prescribing Jokath, clinicians should consider patient‑specific factors and monitor for adverse events.

- Cardiovascular assessment: evaluate for bradycardia or heart block before use. - Respiratory status: avoid in patients with severe asthma or chronic obstructive pulmonary disease. - Contact lens wear: advise patients to remove lenses before instillation and wait before reinserting. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Concomitant ocular drugs: assess for additive pressure‑lowering effects. - Store at room temperature: keep in the original container, protect from moisture and direct light.

Jokath can interact with systemic and ocular medications; careful review is recommended.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers (e.g., propranolol): may cause excessive bradycardia or hypotension. - Calcium channel blockers: increased risk of cardiac conduction abnormalities. - Other ocular beta‑blockers: additive reduction of intraocular pressure may lead to hypotony.

Moderate Interactions (Monitor Closely): - Topical NSAIDs: may increase risk of corneal irritation. - Anticholinergic eye drops: monitor for reduced efficacy of pressure control. - Systemic CYP2D6 inhibitors: may modestly raise timolol plasma levels.